Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Nutex Health (NUTX) Long-Term Debt Issuances (2016 - 2025)

Nutex Health's Long-Term Debt Issuances history spans 11 years, with the latest figure at -$273000.0 for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$273000.0; the TTM value through Sep 2025 reached $273000.0, up 105.43%, while the annual FY2024 figure was $7.0 million, 42.87% up from the prior year.
  • Long-Term Debt Issuances for Q4 2025 was -$273000.0 at Nutex Health, down from $15000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $13.9 million in Q2 2021 and bottomed at -$12.0 million in Q4 2023.
  • The 5-year median for Long-Term Debt Issuances is $2.0 million (2024), against an average of $1.8 million.
  • The largest annual shift saw Long-Term Debt Issuances surged 4561.66% in 2021 before it crashed 300.5% in 2022.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $4.6 million in 2021, then plummeted by 300.5% to -$9.3 million in 2022, then decreased by 29.35% to -$12.0 million in 2023, then soared by 117.44% to $2.1 million in 2024, then crashed by 113.0% to -$273000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Long-Term Debt Issuances are -$273000.0 (Q4 2025), $15000.0 (Q3 2025), and $101000.0 (Q2 2025).